ISPOR 21ST ANNUAL INTERNATIONAL MEETING WORKSHOP EXAMINES METHODOLOGIES FOR EVALUATING GEOSPATIAL ACCESS

Published May 25, 2016
Washington, DC—May 25, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Workshop 23—Methodologies for Evaluating Geospatial Access in Medication Use Studies—was held this afternoon in Washington, DC, USA. The discussion leaders for the session included:
  • Rajesh Balkrishnan, PhD, Professor, Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA
  • Xi Tan, PhD, PharmD, Assistant Professor, Department of Pharmaceutical Systems and Policy, West Virginia University, School of Pharmacy, Morgantown, WV, USA
  • Joseph Donohoe, PhD, Informatics and Special Projects Lead, Mountain-Pacific Quality Health, Helena, Helena, MT, USA
Large database studies that analyze health outcomes for medications often find significant variation in utilization due to differential geographical access. Discussion leaders reviewed newer measures and techniques of geospatial access to medications, including two-step floating catchment area (2SFCA), geographic hot spot analyses, and geographic weighted regression in evaluating the access and utilization of adjuvant endocrine therapy in breast cancer survivors residing in Appalachia, a poor and underserved region in the US with significant geospatial access issues. Presentations and slide decks from the ISPOR 21st Annual International meeting can be found here. Interested parties can follow news and developments from the meeting on social media using the hashtag #ISPORDC.

###

Related Stories

New Research and Policy Priorities Chart a Broader Role for HEOR

Oct 15, 2026

Value in Health announced today the publication of a new commentary that calls for expanding the role of health economics and outcomes research (HEOR) and increasing its impact on real-world decision making.

ISPOR Europe 2026 Plenaries Announced

Sep 30, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Europe 2026 conference. The conference is the leading global event in Europe for health economics and outcomes research (HEOR) and is scheduled for 8-11 November in Vienna, Austria with the theme, “Shaping the Future of Access Through Science and Policy.”

ISPOR and ISPE Publish Joint Real-World Evidence Transparency Position Statement

Sep 29, 2026

Transparency in research enables the public and decision makers to trust the science that underpins real-world evidence (RWE). ISPOR—The Professional Society for Health Economics and Outcomes Research and the International Society for Pharmacoepidemiology (ISPE) have published a joint RWE Transparency Position Statement.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×